1994
DOI: 10.1016/0016-5085(94)90024-8
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of glutamine synthetase in human primary liver cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
59
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 89 publications
(63 citation statements)
references
References 21 publications
4
59
0
Order By: Relevance
“…51 Most importantly, GS is a target gene of ␤-catenin so that its overexpression is associated with mutations of ␤-catenin or with activation of this pathway. [52][53][54] Up-regulation of GS messenger RNA, protein, and activity were shown by Christa et al 52 in human HCC, while Osada et al 55 reported the stepwise increase in GS immunoreactivity from precancerous lesions to early HCC to progressed HCC. The monoclonal antibody from Chemicon International (clone MB302) at a dilution of 1/500 to 1/1000 and amplified with a new short polymer system yields reliable results.…”
Section: Emerging Tumor Markersmentioning
confidence: 94%
“…51 Most importantly, GS is a target gene of ␤-catenin so that its overexpression is associated with mutations of ␤-catenin or with activation of this pathway. [52][53][54] Up-regulation of GS messenger RNA, protein, and activity were shown by Christa et al 52 in human HCC, while Osada et al 55 reported the stepwise increase in GS immunoreactivity from precancerous lesions to early HCC to progressed HCC. The monoclonal antibody from Chemicon International (clone MB302) at a dilution of 1/500 to 1/1000 and amplified with a new short polymer system yields reliable results.…”
Section: Emerging Tumor Markersmentioning
confidence: 94%
“…matic activities of G6P, LDH, SDH, ND, HBDH, and GDH, Immunohistochemical Analysis of the Distribution of GLS. A crossimmunohistochemistry for the demonstration of the GLS pro-reacting rabbit polyclonal antibody was raised against recombinant tein, and in situ hybridization for the demonstration of albu-human GLS as previously described 23 and used in an indirect immumin messenger RNA (mRNA).…”
mentioning
confidence: 99%
“…Because such thickened trabecular structure cannot mix with noncancerous tissue, advanced HCCs show distinct margin even in a liver with an early stage of chronic liver disease. Various tumor markers, that is, HSP70, GPC3, and GS, also show incrementally more intense expression from early to advanced HCCs [25][26][27][28][29][30][31]. Vascularities of the tumors also change according to tumor development.…”
Section: Developmental Process Of Hccs From Early Stage To Advanced Smentioning
confidence: 99%
“…In addition to the morphological criteria, some attempts have been made recently to utilize immunohistochemical markers for the diagnosis of well-differentiated HCCs [25][26][27][28][29][30][31]. Heat shock protein 70 (HSP70) [25,26], glypican 3 (GPC3) [25,[27][28][29], and glutamine synthetase (GS) [25,30,31] have been used independently or in combination.…”
Section: Total Process Of Biopsy Diagnosismentioning
confidence: 99%
See 1 more Smart Citation